Merck & Co., Inc. - Company & Market Research Reports

Home /
Companies /
Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 329
Infectious Diseases Drugs 239
Vaccines 239
Animal Healthcare/Veterinary 191
Endocrine and Metabolic Disorders Drugs 173
Immune Disorders Drugs 155
Animal Pharmaceuticals 134
Central Nervous System Drugs 133
Women's Health 130
Cardiovascular Drugs 126
Pharmaceuticals 114
Musculoskeletal Disorders Drugs 101
Drug Discovery 96
Biopharmaceuticals 94
Respiratory Drugs 81
Oncology 73
Allergy and Immunology 71
Clinical Trials 70
Sexual and Reproductive Health Drugs 70
Liver and Kidney Disorders Drugs 69
Diabetes Drugs 65
Antibiotics 62
Gastrointestinal Drugs 61
Biotechnology 60
Drug Delivery 59
Enzymes 57
Genomics 48
Analgesics 43
Optical Disorders Drugs 42
Dermatological Drugs 42
Brain Cancer Drugs 41
Skin Cancer Drugs 38
Infusions and Injectables 36
Diagnostics 35
Pulmonary Medicine 34
Lymphoma Drugs 34
Cancer Vaccines 33
Pharmaceutical Intermediates 32
Biosimilars and Biosuperiors 32
Hematological Drugs 31
Lung Cancer Drugs 30
Optical 28
HIV/AIDS Drugs 28
Urological Disorders Drugs 28
Pharmaceutical Manufacturing 28
Liver Cancer Drugs 26
Healthcare Services 25
Over the Counter (OTC) Drugs 25
Neurology 24
Immunosuppressive Drugs 24
Prostate Cancer Drugs 23
Infectious Disease Testing 23
Cervical Cancer Drugs 22
Allergy Drugs 22
Breast Cancer Drugs 21
Leukemia Drugs 21
Cardiology 21
Mental Disorders Drugs 19
Psoriasis Drugs 19
Asthma Drugs 18
Colon Cancer Drugs 17
Vitamins and Dietary Supplements 17
Drugs by Therapeutic Area 16
Inhalers and Nebulisers 16
Dermatology 16
E-Healthcare 15
Medical Devices 15
Biomarkers 15
Bladder Cancer Drugs 14
Gastroenterology 14
Hematology 13
Pancreatic Cancer Drugs 13
Pediatrics 13
Alzheimer's Disease Drugs 13
Fertility Services 12
Ovarian Cancer Drugs 12
Nanomedicine 12
Therapeutic Area 11
Urology and Nephrology 11
Generic Drugs 11
Transdermal and Transmucosal Drug Delivery 11
Kidney Cancer Drugs 11
Anti-Obesity Drugs 11
Respiratory Devices 10
Thyroid Cancer Drugs 10
In Vitro Diagnostics 9
Anesthetic Drugs 8
Mental Health 8
Uterine Cancer Drugs 7
Endocrinology 7
Bronchitis Drugs 7
Hepatology 6
Proteomics 6
Healthcare 6
Other Healthcare Facilities 6
Needles and Syringes 5
Laboratory Equipment 5
Company Reports 4
Cough and Cold Drugs 4
Surgical Procedures 4
Cardiovascular Devices 3
Diabetes Devices 3
Hospital Management 3
Molecular Diagnostics 3
Palliative Care 3
Acne Drugs 3
Anxiety Drugs 3
Schizophrenia Drugs 3
Addiction Disorders Drugs 2
Patient Monitoring Equipment 2
Pharmacoeconomics 2
Laboratory Testing 2
Dental 2
Mammography 2
Stem Cells 2
Blood Banking 2
Biomaterials 2
ENT Devices 2
Nursing 2
Surgical Devices 2
Endoscopy 2
Clinical Skills 2
Maternal and Neonatal Care 2
Orthopedic Devices 1
Dialysis 1
Cholesterol Testing 1
Managed Care 1
Neurology Devices 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Anatomy 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

3,366 Results (Page 123 of 169)
- Relevance
  Sort by

Cardiovascular Drugs - Global Strategic Business Report 2026

 Report
November 2026
458 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

Thrombosis Drugs - Global Strategic Business Report 2026

 Report
November 2026
387 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

Anti-Hypertensive Drugs - Global Strategic Business Report 2026

 Report
November 2026
587 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

Cardiotonic Agents - Global Strategic Business Report

 Report
November 2026
568 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

Long QT Syndrome Treatment - Global Strategic Business Report

 Report
November 2026
277 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Lisinopril - Global Strategic Business Report 2026

 Report
November 2026
476 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

Dyslipidemia Drugs - Global Strategic Business Report

 Report
November 2026
268 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

Atherosclerosis Therapeutics - Global Strategic Business Report

 Report
November 2026
181 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

Angina Pectoris Drugs - Global Strategic Business Report 2026

 Report
November 2026
241 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

Heart Failure Drugs - Global Strategic Business Report 2026

 Report
November 2026
155 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

Dilated Cardiomyopathy Therapeutics - Global Strategic Business Report 2026

 Report
November 2026
194 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

Fibrotic Diseases Treatment Market - Global Forecast 2026-2032

 Report
September 2026
194 Pages
Global

From

€3328EUR$3,545USD£2,777GBP

€3698EUR$3,939USD£3,085GBP

Advanced Drug Delivery Systems Markets and Technologies

 Report
February 2024
265 Pages
Global

From

€4366EUR$4,650USD£3,642GBP

Alzheimers Therapeutic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

 Report
August 2022
119 Pages
Global

From

€4225EUR$4,500USD£3,525GBP

Cardiomyopathy Therapies - Global Strategic Business Report 2026

 Report
November 2026
227 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

Bacterial Pneumonia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
180 Pages
Global

From

€4225EUR$4,500USD£3,525GBP

Excipients in Pharmaceuticals: Global Markets to 2029

 Report
September 2024
105 Pages
Global

From

€4366EUR$4,650USD£3,642GBP

Novel Drug Delivery Systems Market - Global Forecast 2026-2032

 Report
September 2026
187 Pages
Global

From

€3328EUR$3,545USD£2,777GBP

€3698EUR$3,939USD£3,085GBP

Hyperlipidemia Drugs - Global Strategic Business Report 2026

 Report
November 2026
289 Pages
Global

From

€5493EUR$5,850USD£4,582GBP

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2026

 Clinical Trials
May 2026
280 Pages
Global

From

€2817EUR$3,000USD£2,350GBP

3,366 Results (Page 123 of 169)
- 1
- 121
- 122
- 123
- 124
- 125

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.